You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

New versus Old Neuroleptics: Efficacy versus Marketing

Journal of Palliative Medicine

Impact Factor: 2.1 / 5-Year Impact Factor: 2.5

Journal Homepage Submission guidelines

Restricted access

Research article

First published online December, 2013

New versus Old Neuroleptics: Efficacy versus Marketing

, , [...], and

Volume 16, Issue 12

https://doi.org/10.1089/jpm.2013.9463

Abstract

Get full access to this article

View all access options for this article.

References

1.

Breitbart

W

, Marotta

R

, Platt

MM

, Weisman

H

, Derevenco

M

, Grau

C

, Corbera

K

, Raymond

S

, Lund

S

, Jacobson

P

: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry, 1996; 153:231–237.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Lupus and Cerebrovascular Accidents

Retricted access

Electroconvulsive therapy (ECT) for catatonia: delay may be risky

Retricted access

Case Management through Productivity Engineering: Part 1: Development of the Intensity of Home Care Acuity Scale

Retricted access

On dying and human suffering